Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma

International Journal of Oncology

Volumn 38, Issue 1, 2011, Pages 41-49

  Sica, Gigliola ^a   Lama, Gina ^a   Anile, Carmelo ^a   Geloso, Maria Concetta ^a   La Torre, Giuseppe ^b   De Bonis, Pasquale ^a   Maira, Giulio ^a   Lauriola, Libero ^a   Jhanwar Uniyal, Meena ^c   Mangiola, Annunziato ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiogenesis; CD105; Glioblastoma; Microvessel density; Nestin; Peritumor tissue

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTINEOPLASTIC AGENT; ENDOGLIN; NESTIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL WALL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPOTENT STEM CELL; NEOVASCULARIZATION (PATHOLOGY); PERICYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; WHITE MATTER;

ACTINS; ADULT; AGED; ANTIGENS, CD; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; RECEPTORS, CELL SURFACE; SUPRATENTORIAL NEOPLASMS;

EID: 78650849925     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000822     Document Type: Article

References (38)

1. Kleihues P, Burger PC, Aldape KD, et al: Glioblastoma. In: WHO Classification of Tumors of the Central Nervous System. 4th edition. Louis DN, Ohgaki H, Wiestler OD and Cavenee WK (eds.) IARC, Lyon, pp33-46, 2007.
2. Rong Y, Durden DL, van Meir EG, et al: Pseudopalisading necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65: 529-539, 2006.
3. Vajkoczy P and Menger MD: Vascular microenvironment in gliomas. J Neurooncol 50: 99-108, 2000.
4. Vajkoczy P, Schilling L, Ulrich A, et al: Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse. J Cereb Blood Flow Metab 18: 510-520, 1998.
5. Deane BR and Lantos PL: The vasculature of experimental brain tumors. Part 1. A sequential light and electron microscope study of angiogenesis. J Neurol Sci 49: 55-66, 1981.
6. Nowacki P and Kojder I: Peritumoral angiogenesis around primary and metastatic brain neoplasms. Morphometric analysis. Folia Neuropathol 39: 95-102, 2001.
7. Bakshi A, Nag TC, Wadhwa S, et al: The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J Neurol Sci 155: 196-203, 1998. (Pubitemid 28139021)
8. De Micheli E, Alfieri A, Pinna G, et al: Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: an intraoperative microdialysis study. Adv Exp Med Biol 483: 621-625, 2000.
9. Cubillos S, Obregón F, Vargas MF, et al: Taurine concentration in human gliomas and meningiomas: tumoral, peritumoral, and extratumoral tissue. Adv Exp Med Biol 583: 419-422, 2006.
10. Dehnhardt M, Zoriy MV, Khan Z, et al: Element distribution is altered in a zone surrounding human glioblastoma multiforme. J Trace Elem Med Biol 22: 17-23, 2008.
11. Stevenson CB, Ehtesham M, McMillan KM, et al: CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery 63: 560-570, 2008.
12. Lama G, Mangiola A, Anile C, et al: Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. Int J Oncol 30: 1333-1342, 2007.
13. Mangiola A, Lama G, Giannitelli C, et al: Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res 13: 6970-6977, 2007.
14. Boutros T, Chevet E and Metrakos P: Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death and cancer. Pharmacol Rev 60: 261-310, 2008.
15. Hoefen RJ and Berk BC: The role of MAP kinases in endothelial activation. Vascul Pharmacol 38: 271-273, 2002.
16. Sugawara K, Kurihara H, Negishi M, et al: Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 82: 345-351, 2002.
17. Dallas NA, Samuel S, Xia L, et al: Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 14: 1931-1937, 2008.
18. Yao Y, Kubota T, Takeuchi H, et al: Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Neuropathology 25: 201-206, 2005.
19. Kumar S, Ghellal A, Li C, et al: Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 59: 856-861, 1999.
20. Tanaka F, Otake Y, Yanagihara K, et al: Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res 7: 3410-3415, 2001.
21. Wikström P, Lissbrant IF, Stattin P, et al: Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51: 268-275, 2002.
22. Dore-Duffy P: Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des 14: 1581-1593, 2008.
23. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al: A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313, 2008.
24. Mangiola A, De Bonis P, Maira G, et al: Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. Cancer 113: 841-846, 2008.
25. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
26. Hoelzinger DB, Mariani L, Weis J, et al: Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7: 7-16, 2005.
27. Kleihues P, Burger PC, Collins VP, et al: Glioblastoma. In: Pathology and Genetics of Tumors of the Nervous System. Kleihues P and Cavenee WK (eds). IARC, Lyon, pp29-39, 2000.
28. Weidner N: Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36: 169-180, 1995.
29. Vermeulen PB, Gasparini G, Fox SB, et al: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32: 2474-2484, 1996. (Pubitemid 27080786)
30. Teranishi N, Naito Z, Ishiwata T, et al: Identification of neovasculature using nestin in colorectal cancer. Int J Oncol 30: 593-603, 2007.
31. Vitolo D, Paradiso P, Uccini S, et al: Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: relation to angiogenesis and spread. Histopathology 28: 521-528, 1996.
32. Feigin I, Allen LB, Lipkin L, et al: The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation. Cancer 11: 264-277, 1958.
33. Morikawa S, Baluk P, Kaidoh T, et al: Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160: 985-1000, 2002.
34. Dore-Duffy P, Katychev A, Wang X, et al: CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab 26: 613-624, 2006.
35. Bello L, Giussani C, Carrabba G, et al. Angiogenesis and invasion in gliomas. Cancer Treat Res 117: 263-284, 2004.
36. Jain RK, Di Tomaso E, Duda DG, et al: Angiogenesis in brain tumors. Nat Rev Neurosci 8: 610-622, 2007.
37. Friedman HS, Prados MD, Wen PY, et al: Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27: 4733-4740, 2009.
38. Ahmadvand D, Rasaee MJ, Rahbarizadeh F, et al: Cell selection and characterization of a novel human endothelial cell specific nanobody. Mol Immunol 46: 1814-1823, 2009.